Pinsent Masons recruits third partner in Amsterdam hiring life sciences specialist

03 Jun 2021 | 08:28 am | 1 min. read

Multinational law firm Pinsent Masons has recruited Life Sciences partner, Machteld Hiemstra in Amsterdam as it develops its Netherlands-based technology, science and industry (TSI) capabilities.

Machteld, who is the firm's third partner in The Netherlands, is a civil and regulatory litigator specialising in regulatory enforcement and compliance with an emphasis on medicines and medical devices regulatory mandates, consumer protection, GDPR, product liability and patent extension disputes.
A life sciences specialist, Machteld will advise on Pan-European and domestic matters including biologics and biotech, generics and biosimilars, medtech and digital health.
Amsterdam office head at Pinsent Masons, Wouter Seinen, said: "Building out capabilities that focus on life sciences regulatory advisory and disputes work will be a game changer for us in Amsterdam.
“Not only will Machteld's experience support the development of our global technology, science and industry sector, it will enable us to tap into opportunities prompted by the relocation of the European Medicines Association to Amsterdam as clients increasingly seek on the ground capabilities. Machteld's expertise will play an important role in adding strength and depth to our pan-European Life Sciences capabilities."
Machteld's hire follows the recruitment of TSI partner Alexander Spoor in May following the launch of Pinsent Masons' Amsterdam presence with the hire of office head Wouter Seinen in February.
Joining from Simmons & Simmons, Machteld has advised a number of high-profile businesses including GSK, Bayer, Abbott and Gilead. Her career incorporates both private practice and in-house experience working with Akzo Nobel as senior legal counsel between 2004 and 2007 where she was responsible for global pharma related product liability matters.
Commenting on her move, Machteld said: "Demand for domestic and international life sciences capabilities is increasing in Netherlands and across continental Europe. I am excited to be joining an international team with an established track record of using law as a business enabler for its clients.”

Key Contacts

Wouter Seinen

Wouter Seinen

Partner, Head of Office, Amsterdam

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises on highest value bonus claim brought before DIFC Court

Multinational law firm Pinsent Masons has successfully represented Mr. Ferri-Ricchi, a foreign exchange trader, in what is believed to be the highest value bonus claim ever brought before the Dubai International Financial Centre Court of First Instance.

Pinsent Masons hires pensions expert

Multinational law firm Pinsent Masons has appointed pensions partner, Ian Mylrea, to join the firm’s financial services sector in Manchester

Pinsent Masons signs lease to move to iconic Sydney address

Multinational law firm Pinsent Masons will continue its strong growth in Australia at a new Sydney address after signing a lease to move into one of the city’s most iconic addresses.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons announces new leadership for Global IP Group and Life Sciences

Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.

Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London

Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.